FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

$2.25 mil. RWD Funding Opportunity

[ Price : $8.95]

CDER and CBER release a $2.25 million funding opportunity announcement to assess the potential utility of real-world data to gener...

CGMP Deviations Seen in Centrient Inspection

[ Price : $8.95]

FDA warns Indias Centrient Pharmaceuticals about significant CGMP deviations in its manufacturing of active pharmaceutical ingredi...

Clinicians Need Refresher on Clinical Trial Statistics: Survey

[ Price : $8.95]

Researchers conclude clinicians are challenged to interpret results from both Bayesian and traditional statistical outputs from cl...

Whats Behind the New LASIK Guidance?

[ Price : $8.95]

Attorney Jeffrey Shapiro says FDA appears to be trying to get LASIK laser manufacturers who have an approved PMA to submit a suppl...

Bill to Advance Pregnant/Lactating Women in Trials

[ Price : $8.95]

Representatives Kathy Castor (D-FL), Brian Fitzpatrick (R-PA), and Lauren Underwood (D-IL) introduce HR 9487, Advancing Safe Medic...

Assign TE Codes for All Approved Drugs: Study

[ Price : $8.95]

A Brookings Institution report suggests ways to speed FDA therapeutic equivalence ratings for injectable drugs approved through th...

Change Antibiotic Development Incentives: Study

[ Price : $8.95]

Harvard Medical School researchers call for new incentives to develop antibiotics that show added value for patients through clini...

Moderna/Merck Cancer Vaccine Meets Endpoint

[ Price : $8.95]

Moderna and Merck say their investigational mRNA cancer vaccine met its endpoint in a Phase 2b melanoma trial.

FDA Clears Bausch Contact Lens Rehydrating Drops

[ Price : $8.95]

FDA clears a Bausch + Lomb 510(k) for its Biotrue Hydration Boost Contact Lens Rehydrating drops.

Doc Group Wants FDA Probe of Musks Neuralink

[ Price : $8.95]

The Physicians Committee for Responsible Medicine calls on FDA to investigate possible good laboratory practice violations by Elon...